文献速递皮肤肿瘤

ATLAS:与黑色素瘤复发最显著相关的患者症状高收益回顾

ATLAS: A positive, high-yield review of patient symptoms most significantly associated with melanoma recurrence.
PubMed 文献 · J Am Acad Dermatol · 2024-08-26

该回顾性队列研究比较有皮肤黑色素瘤病史的复发与未复发患者的人口学与临床特征(含全面系统回顾),提出可用「ATLAS」记忆与复发相关的高收益阳性系统回顾症状;作者认为该模型或有助于临床医生更早发现复发并改善结局。

要点

  • ATLAS包括食欲改变、疲倦、淋巴结肿大、腹痛、气短五项症状。
  • 研究为回顾性设计,复发与未复发队列随访时间存在差异。
  • 该模型旨在帮助治疗医生以较低成本与发病率发现复发。

核心结论

  • 使用ATLAS模型可能让治疗医生有更多机会发现复发性皮肤黑色素瘤并改善结局,同时限制成本与发病率。

研究设计与样本

  • 回顾性队列研究,纳入有皮肤黑色素瘤病史的患者,比较复发与未复发者的人口学与临床特征,包括全面系统回顾。

主要发现

  • 与皮肤黑色素瘤复发相关的高收益阳性系统回顾可用「ATLAS」记忆:食欲改变、疲倦、淋巴结肿大、腹痛、气短。

临床怎么用

  • 临床随访有皮肤黑色素瘤病史者时,可围绕ATLAS五项症状进行阳性系统回顾以提示复发可能。

局限性

  • 回顾性设计。
  • 样本量有限。
  • 复发与未复发队列之间随访时间存在差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: No standardized, evidence-based surveillance practices exist to guide and optimize recurrence detection in patients with cutaneous melanoma. OBJECTIVE: To determine the most high-yield positive review of systems for signaling recurrence in patients with cutaneous melanoma. METHODS: This retrospective cohort study assessed patients with a history of cutaneous melanoma and compared demographic and clinical characteristics, including a comprehensive review of systems, among those who experienced recurrence and those who did not. RESULTS: A high-yield positive review of systems associated with cutaneous melanoma recurrence can be remembered using the mnemonic "ATLAS": Appetite change, Tiredness, Lymph node enlargement, Abdominal pain, and Shortness of breath LIMITATIONS: Retrospective design, limited sample size, and variability in follow-up time between recurrent and nonrecurrent cohorts. CONCLUSION: Any treating physician using this model may have a greater opportunity to detect recurrent cutaneous melanoma and improve outcomes while limiting cost and morbidity.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Everdell E, Borok J, Deutsch A, et al. ATLAS: A positive, high-yield review of patient symptoms most significantly associated with melanoma recurrence. J Am Acad Dermatol. 2024. PMID: 39197498. doi:10.1016/j.jaad.2024.07.1516

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。